SCLX — Scilex Holding Co

NASDAQ · Pharmaceuticals · Pharmaceuticals

$6.83-60.50%Market cap57.06M
Latest Close
$6.83
30-Day Move
-60.5%
Market Cap
$57M
Shares Outstanding
8,490,000
P/B Ratio
15.56
ROE
-64.5%

Analyst consensus: Sell · 6 analysts

NASDAQ:SCLXPharmaceuticals / PharmaceuticalsDelayed public snapshot

Scilex Holding Co

A read-only Alphactor snapshot forScilex Holding Co. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.

Create free accountFundamentals deep-dive →Signals →

Snapshot as of2026-04-21

Topline snapshot

Latest Close

$6.83

30-Day Move

-60.5%

Market Cap

$57M

Shares Outstanding

8,490,000

P/B Ratio

15.56

ROE

-64.5%

Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot

$6.83

-60.5%last 90 delayed daily bars

Market cap$57M

90D High

$18.23

90D Low

$4.20

Avg Volume

57,317

What stands out

Gross margin is running at 68.6%, which gives a quick read on operating quality before you open the full model.

Net margin is -822.8%, useful for comparing SCLX against peers in Pharmaceuticals.

SCLX is down 60.5% over the last 30 trading days shown on this page.

Latest operating income is $-187M, which helps anchor the headline ratios with an actual earnings figure.

Research snapshot

Composite Fair Value

$41.60

Rule of 40

54.2%

Dark Pool Short %

30.2%

OverviewValuationQualityStatements
Fundamentals snapshot

Latest Close

$6.83

30-Day Move

-60.5%

Market Cap

$57M

Shares Outstanding

8,490,000

P/B Ratio

15.56

ROE

-64.5%

ROA

-78.3%

Gross Margin

68.6%

Operating Margin

-655.1%

Net Margin

-822.8%

Debt / Equity

0

Current Ratio

0.16

Latest Revenue

$11M

Financial statement snapshot

Revenue

$11M

Gross Profit

$7M

Operating Income

$-187M

Net Income

$-257M

Gross Margin

6859.0%

Net Margin

-82280.0%

Current Ratio

0.16

Debt / Equity

0.00

Valuation snapshot

Fair Value

$41.60

Upside / Downside

+509.1%

Signal

Undervalued

Implied Growth

-11.5%

DCF

$53.96

EV/Rev

$29.24

Growth Assumption

21.8%

Discount Rate

10.5%

Terminal Growth

2.0%

Base FCF

$19M

Valuation spread

Current Price
$6.83
Composite Fair Value
$41.60
DCF
$53.96
EV/Rev
$29.24

After signup

The full valuation workspace goes deeper

Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.

Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.

Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.

Sign up to open the valuation workspace

Negative growth / decline priced in

Quality snapshot

Altman Z

-13.86

Distress

Piotroski

6

Moderate (4-6)

Cash Conversion

-0.27x

Rule of 40

54.2%

Strong

Annual financial history

Annual performance mix

PeriodRevenueOperating IncomeNet IncomeFree Cash Flow
2021-12-31$31M$-36M$-88M$-29M
2022-12-31$38M$-51M$-23M$-23M
2023-12-31$47M$-105M$-114M$-21M
2024-12-31$57M$-93M$-73M$19M

After signup

The app opens the full statement deep dive

Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.

Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.

Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.

Sign up to open the full statements
NewsInsiderETF Holders
News snapshot

After signup

The full sentiment workspace adds context

Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.

Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.

Sign up to open the full news feed
Insider activity snapshot

Buy Value

$599,820

Sell Value

$13M

Buys

2

Sells

4

Buy Value

$599,820

Sell Value

$13M

Buy/Sell Ratio

0.50x

After signup

The full app goes deeper on insider behavior

Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.

Continue into deeper institutional and alternative-data views once you sign up.

Sign up to open insider detail
Recent insider transactions
DateNameTypeSharesPrice
2026-04-17Ma Stephen HoiBuy650,000$0.15
2026-04-17Ji HenrySell650,000$0.15
2026-04-16Ji HenryBuy3,250,000$0.15
2025-12-30Scilex Holding CoSell9,657,300$0.54
2025-12-29Scilex Holding CoSell7,310,984$0.66
2025-12-26Scilex Holding CoSell3,689,016$0.75
2025-10-08Ma Stephen HoiA60,000$0.00
2025-10-08Chun JayA20,000$0.00
Institutional holders snapshot

Vanguard Group

Filed 2025-08-11

--

--

Qube Research & Technologies

Filed 2025-08-14

--

--

Northern Trust

Filed 2025-08-13

--

--

Invesco

Filed 2025-08-13

--

--

Geode Capital Management

Filed 2026-02-09

--

--

Two Sigma Advisers

Filed 2025-08-14

--

--

BlackRock

Filed 2024-08-13

$13M

--

Dark-pool activity snapshot
Analyst consensus?
Rating(?)

2.17

Consensus

Sell
Target Mean(?)

—

Target High(?)

—

Target Low(?)

—

Analysts

6

Premium previews

See where the deeper analysis goes next

Sign up free
Open a preview card to sample a premium module.

High-intent actions

What you can do after signup

Organic traffic stays on the free tier by default, but signing up lets you save work and continue exploring.

For informational and educational purposes only. Not financial advice. Learn more

Related reading

Research and strategy guides from the alphactor blog.

For informational and educational purposes only. Not financial advice. Learn more